Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Bertagnolli is committed to making clinical trials faster, more inclusive and more responsive.
The COVID virus infected coronary arteries and increased inflammation in atherosclerotic plaques.
Monica Bertagnoli was asked about issues ranging from high drug prices to the opioid crisis to gender-affirming care.
Infants and young children who had COVID produced protective antibodies for much longer than adults.
Study findings shed light on possible causes of long COVID and could lead to more sensitive testing and personalized treatments.
Report findings suggest many cancers were not being diagnosed in a timely manner during the early part of the pandemic.
Shutdown could affect NIH, CDC, community health centers and HIV/AIDS programs, but Medicare and Medicaid payments won’t stop immediately.
Study findings identify a potential marker that could help identify people at high risk of developing long COVID.
Mitochondrial dysfunction has been found in some people with long COVID and other conditions that include fatigue.
NIH-funded research links alterations to inflammatory protein, underscores vaccine importance.
Antibodies crossed the placenta, likely conferring some protection for newborns immediately after birth.
Researchers are working on vaccines that will target multiple flu or coronavirus strains.
Dr. Marrazzo is a renowned HIV and STI expert at the University of Alabama Birmingham.
The first studies, launched on July 31, will focus on viral persistence and cognitive dysfunction.
A better understanding of post-Lyme syndrome may also shed light long COVID and myalgic encephalomyelitis/chronic fatigue syndrome.
Clarifying symptoms may help guide clinical trials to develop treatments for postacute sequelae of SARS-CoV-2.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.